Health Sciences

Penn Researchers Use New Imaging to Show Key Enzyme in Ovarian Cancer

A new imaging test may provide the ability to identify ovarian cancer patients who are candidates for an emerging treatment that targets a key enzyme cancer cells need to survive. Currently, epithelial ovarian cancer patients with BRCA1 mutations are considered candidates for the treatment, but there is no method to measure the enzyme levels to help guide treatment choices.

John Infanti

Two Penn Physicians Awarded SU2C Immuno-Oncology Innovative Research Grants

Two doctors in the Perelman School of Medicine at the University of Pennsylvania have been awarded Immuno-Oncology Innovative Research Grants (IRG) by Stand Up to Cancer (SU2C). Michael Farwell, MD, an assistant professor of Radiology, and Gregory L. Beatty, MD, PhD, an assistant professor of Hematology Oncology, and are two of just 10 researchers to receive these grants.

John Infanti

Link between Common Prostate Cancer Treatment, Dementia Detailed in New Penn Study

A new analysis of patients who have undergone treatment for prostate cancer shows a connection between androgen deprivation therapy (ADT) – a testosterone-lowering therapy and a common treatment for the disease – and dementia, according to researchers from the Perelman School of Medicine at the University of Pennsylvania.

John Infanti

Penn Studies Find Promise for Innovations in Liquid Biopsies

From using fluid in the lungs to better understand the potential of immunotherapy treatments in lung cancer, to tracking circulating tumor cells in prostate cancer, to conducting RNA sequencing of cancer cell clusters from the blood of pancreatic cancer patients, to finding new ways to biopsy tissue from patients who may have esophageal cancer, a series of studies from the Perelman School of Me

John Infanti



In the News


Newsweek

Sugar-coated gold nanoparticles could replace some antibiotics

According to a Penn Medicine study, a new therapy involving laser light and sugar-coated gold nanoparticles can reduce tooth decay and infected wounds without needing antibiotics.

FULL STORY →



Associated Press

A new strategy to attack aggressive brain cancer shrank tumors in two early tests

A clinical trial led by Stephen Bagley of the Perelman School of Medicine suggests that targeting two associated proteins with CAR T cell therapy could be a viable strategy for shrinking brain tumors.

FULL STORY →



New Scientist

Alzheimer’s may be caused by a build-up of fat in brain cells

A study by Michael Haney of the Perelman School of Medicine suggests that the root cause of Alzheimer’s is a build-up of fat droplets in brain cells.

FULL STORY →



The Washington Post

Cats aren’t jerks. They’re just misunderstood

James Serpell of the School of Veterinary Medicine says that the domestic cat suffers from its legacy of being a not-quite-wild animal on the margins of society.

FULL STORY →



WHYY (Philadelphia)

Philadelphia hospital program adds psychologists to bridge mental health services for trauma survivors

A new psychology team at the Penn Trauma Violence Recovery Program has provided about 46 survivors with short- and long- term therapy, featuring remarks from Elinore Kaufman and Lily Brown of the Perelman School of Medicine.

FULL STORY →